A new batch of high-value medical consumables collected by national organizations was officially launched. The tender will be opened on January 13, 2026 to collect drug-coated balloons and urological interventional medical consumables. This is also the sixth batch of high-value medical consumables collected by the country. Unlike the previous five rounds of centralized procurement of high-value medical consumables, this round of procurement has two new highlights: first, it introduced the concept of anchor prices, and the other is the introduction of a multi-cycle mechanism. The reporter analyzed that anchor prices are actually aimed at finding a balance between reducing prices and preventing malicious price pressure. There are two benefits to doing this. First, prevent vicious competition or suicidal offers that kind of push the threshold too low. Second, this mechanism can also break the possibility of group bidding between companies.

A new batch of high-value medical consumables collected by national organizations was officially launched. The tender will be opened on January 13, 2026 to collect drug-coated balloons and urological interventional medical consumables. This is also the sixth batch of high-value medical consumables collected by the country. Unlike the previous five rounds of centralized procurement of high-value medical consumables, this round of procurement has two new highlights: first, it introduced the concept of anchor prices, and the other is the introduction of a multi-cycle mechanism. The reporter analyzed that anchor prices are actually aimed at finding a balance between reducing prices and preventing malicious price pressure. There are two benefits to doing this. First, prevent vicious competition or suicidal offers that kind of push the threshold too low. Second, this mechanism can also break the possibility of group bidding between companies.